Mutations of Hepatitis B Virus S Gene by Hepatitis B Immunoglobulin Administration in Late Pregnancy

Lu Gan,Dongyang Liu,Ming Wei,Caiping Ke,Xiaomei Tang,Xiaomin Xiao
DOI: https://doi.org/10.5897/ajmr12.643
2012-01-01
African Journal of Microbiology Research
Abstract:The safety of hepatitis B immunoglobulin (HBIG) adm inistration in late pregnancy is still controversia l, especially the hepatitis B virus (HBV) mutation-gen erating effects of HBIG. In order to clarify the association between HBV S gene mutations and HBIG a dministration in late pregnancy, 106 HBV carrier mothers and 60 newborns were recruited for the stud y. Peripheral blood specimens were collected from mothers before HBIG administration and delivery, as well as from newborns before vaccine immunization. HBV-DNA was detected by fluorescent q uantitative-polymerase chain reaction (PCR). HBV S gene was amplified by nested PCR and then dir ectly sequenced. Compared with nucleotide sequences and amino acids in HBV S gene of 73 cases in HBIG group, there were no changes after HBIG injection until delivery. The rate of the moth ers infected with genotype C was significantly high er than mothers with genotype B (75.47% vs. 24.53%; P < 0.05). Seven of sixty neonates obtained the results of sequencing. All of the seven newborns we re genotype C. But HBV genotypes were not significantly different in HBV intrauterine transmi ssion ( P > 0.05). Injection of HBIG does not cause mutations of HBV S gene in Chinese pregnant women. HBV genotypes are not the main factors to intrauterine transmission.
What problem does this paper attempt to address?